Quantitative real-time PCR study on persistence of pDNA vaccine pVax-Hsp60 TM814 in beef muscles

Genetic Vaccines and Therapy

Volumn 6, Issue , 2008, Pages

  Orság, Petr ^a   Kvardová, Veronika ^a   Raška, Milan ^b   Miller, Andrew D ^c   Ledvina, Miroslav ^d   Turánek, Jaroslav ^a  

^a VETERINARY RESEARCH INSTITUTE   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; DIAMINE DERIVATIVE; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DNA VACCINE; HEAT SHOCK PROTEIN 60; LIPOSOME; NAKED DNA; PLASMID DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATTLE; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG SENSITIVITY; DRUG TISSUE LEVEL; ELECTROPORATION; INJECTION SITE; LYMPH NODE; MOUSE; MUSCLE TISSUE; NONHUMAN; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE DRUG DOSE;

ANIMALIA; BOS; MUS;

EID: 52449110778     PISSN: None     EISSN: 14790556     Source Type: Journal    
DOI: 10.1186/1479-0556-6-11     Document Type: Article

References (45)

1. Alarcon JB Waine GW McManus DP: Adv Parasitol London: Academic Press Ltd 1999 42 343 410 10050276
2. Vilalta A Mahajan RK Hartikka J Leamy V Martin T Rusalov D Bozoukova V Lalor P Hall K Kaslow DC Rolland A: II. Cationic lipid- formulated plasmid DNA-based Bacillus anthracis vaccine: Evaluation of plasmid DNA persistence and integration potential. Human Gene Therapy 2005, 16:1151-1156. 10.1089/hum.2005.16.1151 16218776
3. Martin T Parker SE Hedstrom R Le T Hoffman SL Norman J Hobart P Lew D: Plasmid DNA malaria vaccine: The potential for genomic integration after intramuscular injection. Human Gene Therapy 1999, 10:759-768. 10.1089/ 10430349950018517 10210143
4. Ledwith BJ Manam S Troilo PJ Barnum AB Pauley CJ Griffiths TG Harper LB Beare CM Bagdon WJ Nichols WW; Plasmid DNA vaccines: Investigation of integration into host cellular DNA following intramuscular injection in mice. Intervirology 2000, 43:258-272. 10.1159/000053993 11251381
5. Wang Z Troilo PJ Wang X Griffiths TG Pacchione SJ Barnum AB Harper LB Pauley CJ Niu Z Denisova L Follmer TT Rizzuto G Ciliberto G Fattori E Monica NL Manam S Ledwith BJ: Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation. Gene Therapy 2004. 11:711-721. 10.1038/sj.gt.3302213 14724672
6. Vilalta A Mahajan RK Hartikka J Rusalov D Martin T Bozoukova V Leamy V Hall K Lalor P Rolland A Kaslow DC: I. Poloxamer-formulated plasmid DNA-based human cytomegalovirus vaccine: Evaluation of plasmid DNA biodistribution/persistence and integration. Human Gene Therapy 2005, 16:1143-1150. 10.1089/hum.2005.16.1143 16218775
7. Coelho-Castelo AAM Trombone AP Rosada RS Santos RR Bonato VLD Sartori A Silva CL: Tissue distribution of a plasmid DNA encoding Hsp65 gene is dependent on the dose administered through intramuscular delivery 2006. 4:1. 1403771 16445866
8. Pal R Yu Q Wang SX Kalyanaraman VS Nair BC Hudacik L Whitney S Keen T Hung CL Hocker L Kennedy JS Markham P Lu S: Definitive toxicology and biodistribution study of a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 (HIV-1) vaccine in rabbits. Vaccine 2006, 24:1225-1234. 10.1016/j.vaccine.2005.07.112 16219399
9. Parker SE Borellini F Wenk ML Hobart P Hoffman SL Hedstrom R Le T Norman JA: Plasmid DNA malaria vaccine: Tissue distribution and safety studies in mice and rabbits. Human Gene Therapy 1999, 10:741-758. 10.1089/ 10430349950018508 10210142
10. Wolff JA Ludtke JJ Acsadi G Williams P Jani A: Long-term persistence of plasmid DNA and foreign gone expression in mouse muscle. Human Molecular Genetics 1992. 1:363-369. 10.1093/hmg/1.6.363 1301910
11. Nichols WW Ledwith BJ Manam SV Troilo PJ: Potential DNA vaccine integration into host cell genome. Annals of the New York Academy of Sciences 1995. 772:30-39. 10.1111/j.1749-6632.1995.tb44729.x 8546411
12. Manam S Ledwith B Barnum AB Troilo PJ Pauley CJ Harper LB Griffiths TG Niu ZT Denisova L Follmer TT Pacchione SJ Wang ZB Beare CM Bagdon WJ Nichols WW: Plasmid DNA vaccines: Tissue distribution and effects of DNA sequence, adjuvants and delivery method on integration into host DNA. Intervirology 2000. 43:273-281. 10.1159/000053994 11251382
13. Parker SE Monteith D Horton H Hof R Hernandez P Vilalta A Hartikka J Hobart P Bentley CE Chang A Hedstrom R Rogers WO Kumar S Hoffman SL Norman JA: Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccine. Gene Therapy 2001, 8:1011-1023. 10.1038/sj.gt.3301491 11438836
14. Kim BM Lee DS Choi JH Kim CY Son M Suh YS Baek KH Park KS Sung YC Kim WB: In vivo kinetics and biodistribution of a HIV-1 DNA vaccine after administration in mice. Archives of Pharmacal Research 2003, 26:493-498. 12877561
15. Imboden M Shi FS Pugh TD Freud AG Thom NJ Hank JA Hao ZL Staelin ST Sondel PM Mahvi DM: Safety of interleukin-12 gene therapy against cancer: A murine biodistribution and toxicity study. Human Gene Therapy 2003, 14:1037-1048. 10.1089/104303403322124765 12885344
16. Armengol G Ruiz LM Orduz S: The injection of plasmid DNA in mouse muscle results in lifelong persistence of DNA, gene expression, and humoral response. Molecular Biotechnology 2004, 27:109-118. 10.1385/MB:27:2:109 15208453
17. Zhang HY Sun SH Guo YJ Chen ZH Huang L Gao YJ Wan B Zhu WJ Xu GX Wang JJ: Tissue distribution of a plasmid DNA containing epitopes of foot-and-mouth disease virus in mice. Vaccine 2005, 23:5632-5640. 10.1016/j.vaccine.2005.06.029 16125283
18. Tuomela M Malm M Wallen M Stanescu L Krohn K Peterson P: Biodistribution and general safety of a naked DNA plasmid, GTU((R))-MultiHIV, in a rat, using a quantitative PCR method. Vaccine 2005, 23:890-896. 10.1016/ j.vaccine.2004.08.004 15603889
19. Quezada A Larson J French M Ponce R Perrard J Durland R Coleman M: Biodistribution and safety studies of hDel-1 plasmid-based gene therapy in mouse and rabbit models. Journal of Pharmacy and Pharmacology 2004, 56:177-185. 10.1211/0022357022584 15005876
20. Mena A Andrew ME Coupar BEH: Rapid dissemination of intramuscularly inoculated DNA vaccines. Immunology and Cell Biology 2001, 79:87-89. 10.1046/j.1440-1711.2001.00979.x
21. Draghia-Akli R Cummings KK Khan AS Brown PA Carpenter RH: Effects of plasmid-mediated growth hormone releasing hormone supplementation in young, healthy Beagle dogs. Journal of Animal Science 2003, 81:2301-2310. 12968706
22. Hanke T McMichael AJ Dennis MJ Sharpe SA Powell LAJ McLoughlin L Crome SJ: Biodistribution and persistence of an MVA-vectored candidate HIV vaccine in SIV-infected rhesus macaques and SCID mice. Vaccine 2005, 23:1507-1514. 10.1016/j.vaccine.2004.08.050 15670887
23. Raska M Rybnikar A Chumela J Belakova J Weigl E: Recombinant protein and DNA vaccines derived from hsp60 Trichophyton mentagrophytes control the clinical course of trichophytosis in bovine species and guinea-pigs. Mycoses 2004, 47:407-417. 10.1111/j.1439-0507.2004.01046.x 15504125
24. Raska M Zemanova E Kafkova L Belakova J Vudattu NK Kopecek P Weigl E; Isolation and characterization of an immunogenic fragment of heat shock protein 60 from Trichophyton mentagrophytes. Mycoses 2004, 47:482-490. 10.1111/j.1439-0507.2004.01046.x 15601454
25. Spagnou S Miller AD Keller M: Lipidic carriers of siRNA: Differences in the formulation, cellular uptake, and delivery with plasmid DNA. Biochemistry 2004. 43:13348-13356. 10.1021/bi048950a 15491141
26. Krcmar P Rencova E: Quantitative detection of species-specific DNA in feedstuffs and fish meals. 2005, 68:1217-1221. 15954711
27. Haworth R Pilling AM: The PCR assay in the preclinical safety evaluation of nucleic acid medicines. Human & Experimental Toxicology 2000, 19:267-276. 10.1191/096032700678815891 10918521
28. Foss GS Rogne S: Gene medication or genetic modification? The devil is in the details. Nature Biotechnology 2003, 21:1280-1281. 10.1038/ nbt1103-1280 14595352
29. FDA CBER. Food and Drug Administration CBER Guidance for Industry Considerations for Plasmid DNA Vaccines for Infectious Disease Indications Fedregister 1998:36413.
30. Bureau MF Naimi S Ibad RT Seguin J Georger C Arnould E Maton L Blanche F Delaere P Schennan D: Intramuscular plasmid DNA electrotransfer biodistribution and degradation. Biochimica et Biophysica Acta-Gene Structure and Expression 2004, 1676:138-148. 10.1016/j.bbaexp.2003.11.005
31. Wolff JA Dowty ME Jiao SS Repetto G Berg RK Ludtke JJ Williams P Slautterback DB: Expression of Naked Plasmids by Cultured Myotubes and Entry of Plasmids Into T-Tubules and Caveolae of Mammalian Skeletal-Muscle. Journal of Cell Science 1992, 103:1249-1261. 1487500
32. Barry ME Pinto-Gonzalez D Orson FM McKenzie GJ Petry GR Barry MA: Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection. Human Gene Therapy 1999, 10:2461-2480. 10.1089/10430349950016816 10543612
33. McMahon: JM Wells DJ: Electroporation for gene transfer to skeletal muscles - Current status. Biodrugs 2004, 18:155-165. 10.2165/ 00063030-200418030-00002 15161333
34. Hartikka; J Sukhu I Buchner C Hazard D Bozoukova V Margalith M Nishioka WK Wheeler CJ Manthorpe M Sawdey M: Electroporation-facilitated delivery of plasmid DNA in skeletal muscle: Plasmid dependence of muscle damage and effect of poloxamer 188. Molecular Therapy 2001, 4:407-415. 10.1006/ mthe.2001.0483 11708877
35. Durieux AC Bonnefoy R Freyssenet D; Kinetic of transgene expression after electrotransfer into skeletal muscle: Importance of promoter origin/strength. Biochimica et Biophysica Acta-General Subjects 2005, 1725:403-409. 10.1016/j.bbagen.2005.06.016 16054757
36. Durieux AC Bonnefoy R Busso T Freyssenet D: In vivo gene electrotransfer into skeletal muscle: Effects of plasmid DNA on the occurrence and extent of muscle damage. Journal of Gene Medicine 2004, 6:809-816. 10.1002/jgm.534 15241788
37. Wang XD Tang JG Xie XL Yang JC Li S Ji JG Gu J: A comprehensive study of optimal conditions for naked plasmid DNA transfer into skeletal muscle by electroporation. Journal of Gene Medicine 2005, 7:1235-1245. 10.1002/ jgm.765 15880605
38. Danko I Williams P Herweijer H Zhang G Latendresse JS Bock I Wolff JA: High expression of naked plasmid DNA in muscles of young rodents. Human Molecular Genetics 1997, 6:1435-1443. 10.1093/hmg/6.9.1435 9285779
39. McMahon JM Signori E Wells KE Fazio VM Wells DJ: Optimisation of electrotransfer of plasmid into skeletal muscle by pretreatment with hyaluronidase - increased expression with reduced muscle damage. Gene Therapy 2001, 8:1264-1270. 10.1038/sj.gt.3301522 11509960
40. Gollins H McMahon J Wells KE Wells DJ: High-efficiency plasmid gene transfer into dystrophic muscle. Gene Therapy 2003, 10:504-512. 10.1038/ sj.gt.3301927 12621454
41. Schertzer: JD Plant DR Lynch GS: Optimizing plasmid-based gene transfer for investigating skeletal muscle structure and function. Molecular Therapy 2006, 13:795-803. 10.1016/j.ymthe.2005.09.019 16309967
42. Schmalbruch H Lewis DM: Dynamics of nuclei of muscle fibers and connective tissue cells in normal and denervated rat muscles. Muscle & Nerve 2000, 23:617-626. 10.1002/ (SICI)1097-4598(200004)23:4<617::AID-MUS22>3.0.CO;2-Y 10716774
43. Hartikka J Bozoukova V Ferrari M Sukhu L Enas J Sawdey M Wloch MK Tonsky K Norman J Manthorpe M Wheeler CJ: Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigens. Vaccine 2001, 19:1911-1923. 10.1016/S0264-410X(00)00445-X 11228361
44. Reyes L Hartikka J Bozoukova V Sukhu L Nishioka W Singh G Ferrari M Enas J Wheeler CJ Manthorpe M Wloch MK: Vaxfectin enhances antigen specific antibody titers and maintains Th1 type immune responses to plasmid DNA immunization. Vaccine 2001, 19:3778-3786. 10.1016/S0264-410X(01)00090-1 11395213
45. Gregoriadis G Bacon A Caparros-Wanderley W McCormack B: A role for liposomes in genetic vaccination. Vaccine 2002m 20:B1-B9. 10.1016/ S0264-410X(02)00514-5 12477411